This 5-month clinical trial is exploring whether an investigational medicine can help reduce symptoms in people aged 18 to 65 who are living with treatment-resistant depression (TRD).
This study is only being conducted at our Melbourne site.
Apply Now
This study is evaluating the safety, tolerance and effects of the investigational treatment, a first-inhuman antibody that targets B cells involved in lupus. The investigational drug is given by intravenous infusion and is being studied to see if it may help reduce disease activity and improve long-term outcomes for people with lupus.
This study is being conducted at our Brisbane clinic.
Apply Now
